Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer
Suspended
300 enrolled
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Suspended
2,400 enrolled
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
Phase 2/3 Suspended
928 enrolled
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/2 Suspended
29 enrolled
CRYOMATASE
Phase NA Suspended
70 enrolled
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Phase 1 Suspended
98 enrolled
Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy
Suspended
500 enrolled
MIRROR
Suspended
20 enrolled
Physiotherapy Program Impact on Breast Cancer-Related Lymphedema
Phase NA Suspended
21 enrolled
Adherence Intervention in Patients With Metastatic Breast Cancer
Phase NA Suspended
35 enrolled
IPT
Phase 3 Suspended
20 enrolled
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Phase 2 Suspended
61 enrolled
RNSM
Phase NA Suspended
30 enrolled
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
Suspended
10 enrolled
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Phase 3 Suspended
201 enrolled 19 charts
A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer
Phase 1/2 Suspended
65 enrolled
Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer
Phase 1 Suspended
24 enrolled
Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer
Suspended
1,694 enrolled
DNX-2440 for Resectable Colorectal Liver Metastasis
Phase 1 Suspended
30 enrolled
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Phase 1 Suspended
220 enrolled
Guangzhou Women's Health Cohort Study (GWHCS)
Suspended
1,000,000 enrolled
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
Phase NA Suspended
36 enrolled
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Phase 2 Suspended
170 enrolled
Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics
Phase NA Suspended
100 enrolled
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Suspended
20 enrolled
Guide for Prioritisation of Patients for Referral to Breast Clinics
Suspended
4,000 enrolled
Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications
Phase NA Suspended
4 enrolled
Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)
Suspended
50 enrolled
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
Suspended
2,000 enrolled
PIKHER2
Phase 1/2 Suspended
106 enrolled
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Phase 1 Suspended
26 enrolled
YoungWomen
Suspended
600 enrolled
Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
Suspended
50 enrolled
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
Phase 3 Suspended
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
Phase 1/2 Suspended
30 enrolled
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Phase 1 Suspended
24 enrolled